Molecular diagnostics in colorectal carcinoma.

作者: Amarpreet Bhalla , Muhammad Zulfiqar , Michael Weindel , Vinod B. Shidham

DOI: 10.1016/J.CLL.2013.10.001

关键词:

摘要: Molecular pathogenesis and classification of colorectal carcinoma are based on the adenoma-carcinoma sequence in Vogelstein model, serrated polyp pathway, microsatellite instability. The genetic basis for hereditary nonpolyposis cancer is detection mutations. Genetic testing Lynch syndrome includes instability, methylator phenotyping, BRAF mutation, molecular testing. makers include quantitative multigene reverse transcriptase-polymerase chain reaction assay KRAS mutation analysis. Potential biomarkers one-step nucleic acid amplification epigenetic inactivation endothelin 2 3 colon cancer. screening approaches using stool DNA under investigation.

参考文章(69)
William K. Funkhouser, Ira M. Lubin, Federico A. Monzon, Barbara A. Zehnbauer, James P. Evans, Shuji Ogino, Jan A. Nowak, Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. The Journal of Molecular Diagnostics. ,vol. 14, pp. 91- 103 ,(2012) , 10.1016/J.JMOLDX.2011.11.001
Henry T. Lynch, Jane F. Lynch, What the physician needs to know about Lynch syndrome: an update. Oncology. ,vol. 19, pp. 455- 463 ,(2005)
Pablo Menéndez, Pedro Villarejo, David Padilla, José M. Menéndez, Jose A. Rodríguez Montes, Diagnostic and prognostic significance of serum microRNAs in colorectal cancer. Journal of Surgical Oncology. ,vol. 107, pp. 217- 220 ,(2013) , 10.1002/JSO.23245
Mark Omundsen, Francis F. Lam, The other colonic polyposis syndromes. Anz Journal of Surgery. ,vol. 82, pp. 675- 681 ,(2012) , 10.1111/J.1445-2197.2012.06140.X
Jon C. Aster, Abul K. Abbas, Vinay Kumar, James A. Perkins, Robbins & Cotran Pathologic Basis of Disease ,(2004)
Karoliina Stefanius, Laura Ylitalo, Anne Tuomisto, Rami Kuivila, Tiina Kantola, Päivi Sirniö, Tuomo J Karttunen, Markus J Mäkinen, Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma Histopathology. ,vol. 58, pp. 679- 692 ,(2011) , 10.1111/J.1365-2559.2011.03821.X
Sarah E. Kerr, Cheryl B. Thomas, Stephen N. Thibodeau, Matthew J. Ferber, Kevin C. Halling, APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests. The Journal of Molecular Diagnostics. ,vol. 15, pp. 31- 43 ,(2013) , 10.1016/J.JMOLDX.2012.07.005
M J O'Connell, J A Laurie, M Kahn, R J Fitzgibbons, C Erlichman, L Shepherd, C G Moertel, W I Kocha, R Pazdur, H S Wieand, J Rubin, A M Vukov, J H Donohue, J E Krook, A Figueredo, Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. Journal of Clinical Oncology. ,vol. 16, pp. 295- 300 ,(1998) , 10.1200/JCO.1998.16.1.295
Ulrich Güller, Andreas Zettl, Mathias Worni, Igor Langer, Daniela Cabalzar‐Wondberg, Carsten T. Viehl, Nicolas Demartines, Markus Zuber, Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging? Cancer. ,vol. 118, pp. 6039- 6045 ,(2012) , 10.1002/CNCR.27667
Alex Mejia, Stephanie Schulz, Terry Hyslop, David S. Weinberg, Scott A. Waldman, Molecular staging individualizing cancer management Journal of Surgical Oncology. ,vol. 105, pp. 468- 474 ,(2012) , 10.1002/JSO.21858